Literature DB >> 23878263

Shear stress activation of nuclear receptor PXR in endothelial detoxification.

Xiaohong Wang1, Xi Fang, Jing Zhou, Zhen Chen, Beilei Zhao, Lei Xiao, Ao Liu, Yi-Shuan J Li, John Y-J Shyy, Youfei Guan, Shu Chien, Nanping Wang.   

Abstract

Endothelial cells (ECs) are constantly exposed to xenobiotics and endobiotics or their metabolites, which perturb EC function, as well as to shear stress, which plays a crucial role in vascular homeostasis. Pregnane X receptor (PXR) is a nuclear receptor and a key regulator of the detoxification of xeno- and endobiotics. Here we show that laminar shear stress (LSS), the atheroprotective flow, activates PXR in ECs, whereas oscillatory shear stress, the atheroprone flow, suppresses PXR. LSS activation of PXR in cultured ECs led to the increased expression of a PXR target gene, multidrug resistance 1 (MDR1). An in vivo study using rats showed that the expression of MDR1 was significantly higher in the endothelium from the descending thoracic aorta, where flow is mostly laminar, than from the inner curvature of aortic arch, where flow is disturbed. Functionally, LSS-activated PXR protects ECs from apoptosis triggered by doxorubicin via the induction of MDR1 and other detoxification genes. PXR also suppressed the expression of proinflammatory adhesion molecules and monocyte adhesion in response to TNF-α and lipopolysaccharide. Overexpression of a constitutively active PXR in rat carotid arteries potently attenuated proinflammatory responses. In addition, cDNA microarray revealed a large number of the PXR-activated endothelial genes whose products are responsible for major steps of detoxification, including phase I and II metabolizing enzymes and transporters. These detoxification genes in ECs are induced by LSS in ECs in a PXR-dependent manner. In conclusion, our results indicate that PXR represents a flow-activated detoxification system to protect ECs against damage by xeno- and endobiotics.

Entities:  

Keywords:  endothelial homeostasis; gene regulation; hemodynamics; nuclear hormone receptor

Mesh:

Substances:

Year:  2013        PMID: 23878263      PMCID: PMC3740860          DOI: 10.1073/pnas.1312065110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2.

Authors:  Guohao Dai; Saran Vaughn; Yuzhi Zhang; Eric T Wang; Guillermo Garcia-Cardena; Michael A Gimbrone
Journal:  Circ Res       Date:  2007-08-02       Impact factor: 17.367

2.  The role of peroxisomal ABC transporters in the mouse adrenal gland: the loss of Abcd2 (ALDR), Not Abcd1 (ALD), causes oxidative damage.

Authors:  Jyh-Feng Lu; Emily Barron-Casella; Rebecca Deering; Ann K Heinzer; Ann B Moser; Karen L deMesy Bentley; Gary S Wand; Martina C McGuinness; Zhengtong Pei; Paul A Watkins; Aurora Pujol; Kirby D Smith; James M Powers
Journal:  Lab Invest       Date:  2007-01-29       Impact factor: 5.662

3.  Acetylation of pregnane X receptor protein determines selective function independent of ligand activation.

Authors:  Arunima Biswas; Danielle Pasquel; Rakesh Kumar Tyagi; Sridhar Mani
Journal:  Biochem Biophys Res Commun       Date:  2011-02-15       Impact factor: 3.575

4.  Regulation of vascular tone during pregnancy: a novel role for the pregnane X receptor.

Authors:  Kathryn A Hagedorn; Christy-Lynn Cooke; John R Falck; Bryan F Mitchell; Sandra T Davidge
Journal:  Hypertension       Date:  2006-12-11       Impact factor: 10.190

5.  Pregnane X receptor is SUMOylated to repress the inflammatory response.

Authors:  Gang Hu; Chenshu Xu; Jeff L Staudinger
Journal:  J Pharmacol Exp Ther       Date:  2010-08-18       Impact factor: 4.030

6.  Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib).

Authors:  N Barry Elkind; Zsófia Szentpétery; Agota Apáti; Csilla Ozvegy-Laczka; György Várady; Olga Ujhelly; Katalin Szabó; László Homolya; András Váradi; László Buday; György Kéri; Katalin Német; Balázs Sarkadi
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

7.  Laminar shear stress regulates liver X receptor in vascular endothelial cells.

Authors:  Minjia Zhu; Yi Fu; Yingjian Hou; Nanping Wang; Youfei Guan; Chaoshu Tang; John Y-J Shyy; Yi Zhu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-12-20       Impact factor: 8.311

8.  Laminar shear stress up-regulates the expression of stearoyl-CoA desaturase-1 in vascular endothelial cells.

Authors:  Xiaomei Qin; Jianwei Tian; Peng Zhang; Yanbo Fan; Li Chen; Youfei Guan; Yi Fu; Yi Zhu; Shu Chien; Nanping Wang
Journal:  Cardiovasc Res       Date:  2007-02-20       Impact factor: 10.787

9.  Effect of HMGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line.

Authors:  Céline Bertrand-Thiebault; Christine Masson; Gérard Siest; Anne-Marie Batt; Sophie Visvikis-Siest
Journal:  J Cardiovasc Pharmacol       Date:  2007-05       Impact factor: 3.105

10.  The role of shear stress in Blood-Brain Barrier endothelial physiology.

Authors:  Luca Cucullo; Mohammed Hossain; Vikram Puvenna; Nicola Marchi; Damir Janigro
Journal:  BMC Neurosci       Date:  2011-05-11       Impact factor: 3.288

View more
  23 in total

1.  Lack of CAR impacts neuronal function and cerebrovascular integrity in vivo.

Authors:  Baddreddine Boussadia; Giuseppe Gangarossa; Laila Mselli-Lakhal; Marie-Claude Rousset; Frederic de Bock; Frederic Lassere; Chaitali Ghosh; Jean-Marc Pascussi; Damir Janigro; Nicola Marchi
Journal:  Exp Neurol       Date:  2016-05-27       Impact factor: 5.330

2.  Shear-dependent attenuation of cellular ROS levels can suppress proinflammatory cytokine injury to human brain microvascular endothelial barrier properties.

Authors:  Keith D Rochfort; Laura E Collins; Alisha McLoughlin; Philip M Cummins
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-20       Impact factor: 6.200

Review 3.  Novel functions of PXR in cardiometabolic disease.

Authors:  Changcheng Zhou
Journal:  Biochim Biophys Acta       Date:  2016-02-26

4.  Activation of PPAR-δ induces microRNA-100 and decreases the uptake of very low-density lipoprotein in endothelial cells.

Authors:  Xi Fang; Li Fang; Ao Liu; Xiaohong Wang; Beilei Zhao; Nanping Wang
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

Review 5.  The role of endothelial mechanosensitive genes in atherosclerosis and omics approaches.

Authors:  Rachel D Simmons; Sandeep Kumar; Hanjoong Jo
Journal:  Arch Biochem Biophys       Date:  2015-12-11       Impact factor: 4.013

6.  Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR.

Authors:  Satyanarayana R Pondugula; Patrick C Flannery; Kodye L Abbott; Elaine S Coleman; Sridhar Mani; Temesgen Samuel; Wen Xie
Journal:  Toxicol Lett       Date:  2014-12-24       Impact factor: 4.372

7.  Ginkgolide B protects human umbilical vein endothelial cells against xenobiotic injuries via PXR activation.

Authors:  Tao Zhou; Wen-ting You; Zeng-chun Ma; Qian-de Liang; Hong-ling Tan; Cheng-rong Xiao; Xiang-lin Tang; Bo-li Zhang; Yu-guang Wang; Yue Gao
Journal:  Acta Pharmacol Sin       Date:  2016-01-18       Impact factor: 6.150

Review 8.  Shear stress-initiated signaling and its regulation of endothelial function.

Authors:  Jing Zhou; Yi-Shuan Li; Shu Chien
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-29       Impact factor: 8.311

9.  Xenobiotic pregnane X receptor (PXR) regulates innate immunity via activation of NLRP3 inflammasome in vascular endothelial cells.

Authors:  Shaolan Wang; Ting Lei; Kang Zhang; Wenxiang Zhao; Li Fang; Baochang Lai; Jie Han; Lei Xiao; Nanping Wang
Journal:  J Biol Chem       Date:  2014-09-08       Impact factor: 5.157

Review 10.  Nuclear receptors in vascular biology.

Authors:  David Bishop-Bailey
Journal:  Curr Atheroscler Rep       Date:  2015-05       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.